English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

ABSTRACT. Nuclear factor-κB (NF-κB) regulates many genes involved in renal pathophysiologic processes. It was previously demonstrated that angiotensin II (AngII) and its amino-terminal degradation product AngIII activate NF-κB in mesangial cells. However, which are the Ang receptor subtypes involved in the NF-κB pathway and whether these Ang peptides act through the same or different receptors in mesangial cells have not been evaluated. Under the culture conditions used, quiescent rat mesangial cells expressed both AT 1 and AT 2 receptors. To investigate the receptors involved in the NF-κB pathway, two different approaches were used, i.e. , pharmacologic studies, using specific AT 1 and AT 2 receptor antagonists and agonists, and studies in AT 1 receptor-knockout mice. In cultured rat mesangial cells, both AT 1 and AT 2 receptor antagonists inhibited AngII-induced NF-κB DNA binding activity, whereas NF-κB activation elicited by AngIII was mainly blocked by the AT 2 receptor antagonist. Similar results were observed for cytosolic IκBα degradation. An AT 2 receptor agonist also activated NF-κB. In AT 1 receptor-knockout murine mesangial cells, AngIII and AngII increased NF-κB activity and degraded cytosolic IκBα; both processes were blocked by the AT 2 receptor antagonist. These data demonstrate that, in mesangial cells, NF-κB activation is mediated by AT 1 and AT 2 receptors, suggesting a novel intracellular signaling mechanism for AT 2 receptors in the kidney. Some differences in Ang peptide receptor-mediated responses were also observed. AngII activates NF-κB via AT 1 and AT 2 receptors, whereas AngIII acts mainly via AT 2 receptors. These results suggest the potential involvement of the AngIII/AT 2 receptor/NF-κB pathway in pathophysiologic processes in the kidney and provide a better understanding of the renin-angiotensin system.

Angiotensin III Activates Nuclear Transcription Factor-κB in Cultured Mesangial Cells Mainly via AT2 Receptors